Cheap labor and global supply chains are among the obstacles to President Trump’s plan to bring generic drug manufacturing back home.
America Wants to Make More Generic Drugs. India Shows Why That’s Hard.
The New York Times – Business:
This post first appeared in The New York Times – Business. Read the original article.
Written by
in
Leave a Reply